Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is often managed with inhaled long-acting muscarinic antagonists (LAMAs), yet real-world data on healthcare resource utilization (HRU) by inhaler type are lacking. This study compared HRU after LAMA initiation with a soft mist inhaler (SMI) ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, David, Bengtson, Lindsay G S, Elliott, Caitlin, Buikema, Ami R, Franchino-Elder, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732756/
https://www.ncbi.nlm.nih.gov/pubmed/33324047
http://dx.doi.org/10.2147/COPD.S284678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732756/
https://www.ncbi.nlm.nih.gov/pubmed/33324047
http://dx.doi.org/10.2147/COPD.S284678

Ejemplares similares